首页 | 本学科首页   官方微博 | 高级检索  
检索        

盐酸米托蒽醌脂质体的药效学及毒性研究
引用本文:赵倩,王彩霞,邱云良,杨汉煜,魏娜,王炳森,吕晶晶.盐酸米托蒽醌脂质体的药效学及毒性研究[J].中国药理学通报,2011,27(12):1745-1748.
作者姓名:赵倩  王彩霞  邱云良  杨汉煜  魏娜  王炳森  吕晶晶
作者单位:1. 河北省制剂工程技术研究中心,河北,石家庄,050051;石药集团中奇制药技术(石家庄)有限公司,河北,石家庄,050051
2. 国家上海新药安全评价研究中心,上海,201203
基金项目:国家高技术研究发展计划(863计划)资助项目
摘    要:目的对盐酸米托蒽醌脂质体(Mit-lipo)与盐酸米托蒽醌普通制剂(Mit-inj)进行药效学及毒性比较研究。方法采用小鼠肝癌H22、小鼠前列腺癌RM-1移植肿瘤模型探讨Mit-lipo的抗肿瘤作用;犬急性毒性、大鼠和犬长期毒性研究比较Mit-lipo和Mit-inj毒性差异。结果 Mit-lipo 1、2、4和6 mg.kg-1各剂量对H22实体瘤的抑瘤率分别为75.1%、76.5%、90.1%和93.8%,也可剂量依赖性抑制小鼠前列腺癌RM-1肿瘤的生长,与等剂量的Mit-inj相比疗效明显增强。犬急性毒性结果表明Mit-lipo最大耐受剂量(MTD)为2.0 mg.kg-1,毒性表现为轻微至中度的皮肤毒性,给药4周后皮肤毒性逐渐减轻。大鼠长期毒性结果表明Mit-lipo可明显降低Mit-inj引起的骨髓毒性,并产生新的皮肤毒性反应。犬长期毒性结果表明Mit-lipo 0.1、0.3和0.45mg.kg-1组主要毒性反应为轻微至轻度的皮肤毒性反应,主要毒性靶器官为睾丸和皮肤,MTD为0.45 mg.kg-1,Mit-inj0.45 mg.kg-1可致WBC和PLT值降低和睾丸毒性病变。结论与普通制剂相比,米托蒽醌脂质体的体内抑瘤效果明显增强,且骨髓毒性明显降低。

关 键 词:米托蒽醌  脂质体  药效学  H22  RM-1  急性毒性  长期毒性

Pharmacodynamics and toxicity of liposomal mitoxantrone hydrochloride
ZHAO Qian,WANG Cai-xia,QIU Yun-liang,YANG Han-yu,WEI Na,WANG Bing-sen,LU Jing-jing.Pharmacodynamics and toxicity of liposomal mitoxantrone hydrochloride[J].Chinese Pharmacological Bulletin,2011,27(12):1745-1748.
Authors:ZHAO Qian  WANG Cai-xia  QIU Yun-liang  YANG Han-yu  WEI Na  WANG Bing-sen  LU Jing-jing
Institution:ZHAO Qian1,2,WANG Cai-xia1,QIU Yun-liang3,YANG Han-yu1,WEI Na1,WANG Bing-sen3,Lü Jing-jing1,2(1.Hebei Pharmaceutical Technology and Engineering Research Center,Shijiazhuang 050051,China,2.CSPC Zhongqi Pharmaceutical Technology(Shijiazhuang) Co.,Ltd,3.National Shanghai Center for New Drug Safety Evaluation and Research,Shanghai 201203,China)
Abstract:Aim To compare the pharmacodynamics and toxicity of liposomal mitoxantrone(Mit-lipo) and free mitoxantrone(Mit-inj).Methods The antineoplastic effect of Mit-lipo was evaluated in H22 and RM-1 mice xenograft tumor model.The toxic differences between Mit-lipo and Mit-inj were performed through acute toxicity of dogs and long-term toxicity of rats and dogs.Result The tumor-inhibition rates of Mit-lipo(1,2,4 and 6 mg·kg-1) in H22 bearing mice were 75.1%,76.5%,90.1% and 93.8% respectively,and the same doses also inhibited RM-1 tumor growth in a dose-dependent manner.The antitumor effect studies showed that Mit-lipo significantly improved the therapeutic effect in comparison with free drug.The results of acute toxicity of dogs showed that maximum tolerated dose of Mit-lipo was 2.0 mg·kg-1 with the dermal toxicity from mild to moderate,and the toxicity resumed slowly after dosing four weeks.In long-term toxicity of rats,the bone marrow and dermal toxicity were observed in Mit-lipo,and the suppression of bone marrow was reduced significantly compared with Mit-inj.In the long-term toxicity of dogs study,mild dermal toxicity was observed at the dose of 0.1,0.3 and 0.45 mg·kg-1 of Mit-lipo,and the target organs were testis and skin.The maximum tolerated dose of Mit-lipo was 0.45 mg·kg-1,and Mit-inj(0.45 mg·kg-1) resulted in the reduce of WBC and PLT and the lesions of testis.Conclusion Compared with Mit-inj,Mit-lipo can increase therapeutic effect and improve toxicity of the bone marrow obviously.
Keywords:mitoxantrone  liposome  pharmacodynamics  H22  RM-1  acute toxicity  long-term toxicity  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号